|
1
|
Filho AM, Laversanne M, Ferlay J, Colombet
M, Piñeros M, Znaor A, Parkin DM, Soerjomataram I and Bray F: The
GLOBOCAN 2022 cancer estimates: Data sources, methods, and a
snapshot of the cancer burden worldwide. Int J Cancer.
156:1336–1346. 2025. View Article : Google Scholar
|
|
2
|
Wang H, Niu X, Jin Z, Zhang S, Fan R, Xiao
H and Hu SS: Immunotherapy resistance in non-small cell lung
cancer: From mechanisms to therapeutic opportunities. J Exp Clin
Cancer Res. 44:2502025. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu X, Tuerxun H and Zhao Y, Li Y, Wen S,
Li X and Zhao Y: Crosstalk between ferroptosis and autophagy:
Broaden horizons of cancer therapy. J Transl Med. 23:182025.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song YJ, Zhang SS, Guo XL, Sun K, Han ZP,
Li R, Zhao QD, Deng WJ, Xie XQ, Zhang JW, et al: Autophagy
contributes to the survival of CD133+ liver cancer stem cells in
the hypoxic and nutrient-deprived tumor microenvironment. Cancer
Lett. 339:70–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cui Y, Cao X, Zhang Y, Fu C, Li D, Sun Y,
Zhang Y, Xu T, Tsukamoto T, Cao D and Jiang J: Protein phosphatase
1 regulatory subunit 15 A (PPP1R15A) promoted the progression of
gastric cancer by activating cell autophagy under energy stress. J
Exp Clin Cancer Res. 44:522025. View Article : Google Scholar
|
|
6
|
Wu X, Wu J, Dai T, Wang Q, Cai S, Wei X,
Chen J and Jiang Z: β-elemene promotes miR-127-3p maturation,
induces NSCLCs autophagy, and enhances macrophage M1 polarization
through exosomal communication. J Pharm Anal. 14:1009612024.
View Article : Google Scholar
|
|
7
|
Fernandez-Acosta R, Vintea I, Koeken I,
Hassannia B and Vanden Berghe T: Harnessing ferroptosis for
precision oncology: Challenges and prospects. BMC Biol. 23:572025.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He Y, Lin Y, Song J, Song M, Nie X, Sun H,
Xu C, Han Z and Cai J: From mechanisms to medicine: Ferroptosis as
a Therapeutic target in liver disorders. Cell Commun Signal.
23:1252025. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu K, Vaughan AJ, Bossowski JP, Hao Y,
Ziogou A, Kim SM, Kim TH, Nakamura MN, Pillai R, Mancini M, et al:
Targeting FSP1 triggers ferroptosis in lung cancer. Nature.
649:487–495. 2026. View Article : Google Scholar :
|
|
10
|
Peng S, Chen G, Yu KN, Feng Y, Zhao L,
Yang M, Cao W, Almahi WAA, Sun M, Xu Y, et al: Synergism of
non-thermal plasma and low concentration RSL3 triggers ferroptosis
via promoting xCT lysosomal degradation through ROS/AMPK/mTOR axis
in lung cancer cells. Cell Commun Signal. 22:1122024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu Z, Zhang Y, Zhong W, Wu K, Zhong T and
Jiang T: Targeting ferroptosis: A promising approach for treating
lung carcinoma. Cell Death Discov. 11:332025. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bian Y, Shan G, Liang J, Hu Z, Sui Q, Shi
H, Wang Q, Bi G and Zhan C: Retinoic acid receptor alpha inhibits
ferroptosis by promoting thioredoxin and protein phosphatase 1F in
lung adenocarcinoma. Commun Biol. 7:7512024. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Al Matrafi TA: Deciphering the role of
TMEM164 in autophagy-mediated ferroptosis and immune modulation in
non-small cell lung cancer. Cell Immunol. 409-410:1049152025.
View Article : Google Scholar
|
|
14
|
Yu F, Zhang Q, Liu H, Liu J, Yang S, Luo
X, Liu W, Zheng H, Liu Q, Cui Y, et al: Dynamic O-GlcNAcylation
coordinates ferritinophagy and mitophagy to activate ferroptosis.
Cell Discov. 8:402022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia M, Yue X, Sun W, Zhou Q, Chang C, Gong
W, Feng J, Li X, Zhan R, Mo K, et al: ULK1-mediated metabolic
reprogramming regulates Vps34 lipid kinase activity by its
lactylation. Sci Adv. 9:eadg49932023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pyo KE, Kim CR, Lee M, Kim JS, Kim KI and
Baek SH: ULK1 O-GlcNAcylation is crucial for activating VPS34 via
ATG14L during autophagy initiation. Cell Rep. 25:2878–2890.e4.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ghazi PC, O'Toole KT, Srinivas Boggaram S,
Scherzer MT, Silvis MR, Zhang Y, Bogdan M, Smith BD, Lozano G,
Flynn DL, et al: Inhibition of ULK1/2 and KRAS(G12C) controls tumor
growth in preclinical models of lung cancer. Elife. 13:RP969922024.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Changotra H, Kaur S, Yadav SS, Gupta GL,
Parkash J and Duseja A: ATG5: A central autophagy regulator
implicated in various human diseases. Cell Biochem Funct.
40:650–667. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Runwal G, Stamatakou E, Siddiqi FH, Puri
C, Zhu Y and Rubinsztein DC: LC3-positive structures are prominent
in autophagy-deficient cells. Sci Rep. 9:101472019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gómez-Virgilio L, Silva-Lucero MD,
Flores-Morelos DS, Gallardo-Nieto J, Lopez-Toledo G,
Abarca-Fernandez AM, Zacapala-Gómez AE, Luna-Muñoz J, Montiel-Sosa
F, Soto-Rojas LO, et al: Autophagy: A key regulator of homeostasis
and disease: An overview of molecular mechanisms and modulators.
Cells. 11:22622022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Restrepo LJ and Baehrecke EH: Regulation
and functions of autophagy during animal development. J Mol Biol.
436:1684732024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fang C, Wu W, Ni Z, Liu Y, Luo J, Zhou Y,
Gong C, Hu D, Yao C, Chen X, et al: Ailanthone inhibits non-small
cell lung cancer growth and metastasis through targeting
UPF1/GAS5/ULK1 signaling pathway. Phytomedicine. 128:1553332024.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ding X, Li X, Jiang Y, Li Y, Li H, Shang
L, Feng G, Zhang H, Xu Z, Yang L, et al: RGS20 promotes non-small
cell lung carcinoma proliferation via autophagy activation and
inhibition of the PKA-Hippo signaling pathway. Cancer Cell Int.
24:932024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liang DM, Li YJ, Zhang JX, Shen HH, Wu CX,
Xie N, Liang Y, Li YM, Xue JN, Sun HF, et al: m6A-methylated
KCTD21-AS1 regulates macrophage phagocytosis through CD47 and cell
autophagy through TIPR. Commun Biol. 7:2152024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wen Y, Sun X, Zeng L, Liang S, Li D, Chen
X, Zeng F, Zhang C, Wang Q, Zhong Q, et al: CDK4/6 inhibitors
impede chemoresistance and inhibit tumor growth of small cell lung
cancer. Adv Sci (Weinh). 11:e24006662024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen J, Gou Z, Yang G, Zhou L, Kim AN, Shi
W and Zhou Y: Ferroptosis, a distinct form of cell death, and
research progress on its modulators. Pharmaceuticals (Basel).
18:17852025. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Henning Y, Blind US, Larafa S, Matschke J
and Fandrey J: Hypoxia aggravates ferroptosis in RPE cells by
promoting the Fenton reaction. Cell Death Dis. 13:6622022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ursini F and Maiorino M: Lipid
peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic
Biol Med. 152:175–185. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Griffiths K, Ida T, Morita M, Lamb RJ, Lee
JJ, Frenneaux MP, Fukuto JM, Akaike T, Feelisch M and Madhani M:
Cysteine hydropersulfide reduces lipid peroxidation and protects
against myocardial ischaemia-reperfusion injury-are endogenous
persulfides mediators of ischaemic preconditioning? Redox Biol.
60:1026052023. View Article : Google Scholar
|
|
30
|
Yao F, Zhao Y, Wang G, Zhao M, Hong X, Ye
Z, Dong F, Li W and Deng Q: Exosomal lncRNA ROR1-AS1 from
cancer-associated fibroblasts inhibits ferroptosis of lung cancer
cells through the IGF2BP1/SLC7A11 signal axis. Cell Signal.
120:1112212024. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan RY, Liu D, Guo HJ, Liu M, Lv D,
Björkblom B, Wu M, Yu H, Leng H, Lu B, et al: LAPTM4B counteracts
ferroptosis via suppressing the ubiquitin-proteasome degradation of
SLC7A11 in non-small cell lung cancer. Cell Death Dis. 15:4362024.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li K, Yang B, Du Y, Ding Y, Shen S, Sun Z,
Liu Y, Wang Y, Cao S, Ren W, et al: The HOXC10/NOD1/ERK axis drives
osteolytic bone metastasis of pan-KRAS-mutant lung cancer. Bone
Res. 12:472024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma R, Yang D, Wang P, Zhang Z, Zhang X,
Song J, Liu H, Liu S, Zhang Y and Zou L: Oncogenic RIT1 mutations
confer ferroptosis vulnerability in lung adenocarcinoma. Biol
Direct. 20:192025. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim JW, Min DW, Kim D, Kim J, Kim MJ, Lim
H and Lee JY: GPX4 overexpressed non-small cell lung cancer cells
are sensitive to RSL3-induced ferroptosis. Sci Rep. 13:88722023.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu KY, Wei GX, Qi WH, Ye C, Liu Y, Wang S,
Yang F and Tang J: CircPOLA2 sensitizes non-small cell lung cancer
cells to ferroptosis and suppresses tumorigenesis via the
Merlin-YAP signaling pathway. iScience. 27:110832024. View Article : Google Scholar
|
|
36
|
Tang D, Chen X, Kang R and Kroemer G:
Ferroptosis: Molecular mechanisms and health implications. Cell
Res. 31:107–125. 2021. View Article : Google Scholar :
|
|
37
|
Wang B, Wang Y, Zhang J, Hu C, Jiang J, Li
Y and Peng Z: ROS-induced lipid peroxidation modulates cell death
outcome: mechanisms behind apoptosis, autophagy, and ferroptosis.
Arch Toxicol. 97:1439–1451. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liao H, Liu S, Ma Q, Huang H, Goel A,
Torabian P, Mohan CD and Duan C: Endoplasmic reticulum stress
induced autophagy in cancer and its potential interactions with
apoptosis and ferroptosis. Biochim Biophys Acta Mol Cell Res.
1872:1198692025. View Article : Google Scholar
|
|
39
|
Luo C, Liang H, Ji M, Ye C, Lin Y, Guo Y,
Zhang Z, Shu Y, Jin X, Lu S, et al: Autophagy induced by mechanical
stress sensitizes cells to ferroptosis by NCOA4-FTH1 axis.
Autophagy. 21:1263–1282. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang M, Zeng G, Xiong B, Zhu X, Guo J,
Chen D, Zhang S, Luo M, Guo L and Cai L: ALOX5 promotes
autophagy-dependent ferroptosis by activating the AMPK/mTOR pathway
in melanoma. Biochem Pharmacol. 212:1155542023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Y, Hu Y, Xu R, Jin X and Jiao W:
Plin2 inhibits autophagy via activating AKT/mTOR pathway in
non-small cell lung cancer. Exp Cell Res. 435:1139552024.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen S, Cai D, Zhao Q, Wu J, Zhou X, Xu H,
Li X, Zhang R, Peng W, Li G and Nan A: NSUN2-mediated m5C
modification of circFAM190B promotes lung cancer progression by
inhibiting cellular autophagy. Int J Biol Macromol. 306:1415282025.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li XQ, Cheng XJ, Wu J, Wu KF and Liu T:
Targeted inhibition of the PI3K/AKT/mTOR pathway by
(+)-anthrabenzoxocinone induces cell cycle arrest, apoptosis, and
autophagy in non-small cell lung cancer. Cell Mol Biol Lett.
29:582024. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee S, Hwang N, Seok BG, Lee S, Lee SJ and
Chung SW: Autophagy mediates an amplification loop during
ferroptosis. Cell Death Dis. 14:4642023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Su Y, Jin W, Niu J, Lyu X, Hao Q, Lyu Q,
Sheng N, Liu Z and Yu X: Harnessing an MMP-independent NIR probe
unveiling the different mitochondrial cristae changes during
mitophagy and ferroptosis under STED microscopy. Anal Chem.
97:2906–2913. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu S, Chen JH, Li LC, Ye ZP, Liu JN, Chen
YH, Hu BX, Tang JH, Feng GK, Li ZM, et al: Susceptibility of
mitophagy-deficient tumors to ferroptosis induction by relieving
the suppression of lipid peroxidation. Adv Sci (Weinh).
12:e24125932025. View Article : Google Scholar :
|
|
47
|
Yan Y, Ran X, Zhou Z, Gu Y, Wang R, Qiu C,
Sun Y and Wang J, Xiao J, Lu Y and Wang J: FGF21 inhibits
ferroptosis caused by mitochondrial damage to promote the repair of
peripheral nerve injury. Front Pharmacol. 15:13586462024.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yamashita SI, Sugiura Y, Matsuoka Y, Maeda
R, Inoue K, Furukawa K, Fukuda T, Chan DC and Kanki T: Mitophagy
mediated by BNIP3 and NIX protects against ferroptosis by
downregulating mitochondrial reactive oxygen species. Cell Death
Differ. 31:651–661. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Han Z, Wang B, Wen YQ, Li YN, Feng CX,
Ding XS, Shen Y, Yang Q and Gao L: Acteoside alleviates lipid
peroxidation by enhancing Nrf2-mediated mitophagy to inhibit
ferroptosis for neuroprotection in Parkinson's disease. Free Radic
Biol Med. 223:493–505. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gao G and Zhang X: Broadening horizons:
Research on ferroptosis in lung cancer and its potential
therapeutic targets. Front Immunol. 16:15428442025. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li Y, Du Y, Zhou Y, Chen Q, Luo Z, Ren Y,
Chen X and Chen G: Iron and copper: Critical executioners of
ferroptosis, cuproptosis and other forms of cell death. Cell Commun
Signal. 21:3272023. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Subburayan K, Thayyullathil F,
Pallichankandy S, Cheratta AR, Alakkal A, Sultana M, Drou N, Arshad
M, Palanikumar L, Magzoub M, et al: Tumor suppressor Par-4
activates autophagy-dependent ferroptosis. Commun Biol. 7:7322024.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Forcina GC and Dixon SJ: GPX4 at the
crossroads of lipid homeostasis and ferroptosis. Proteomics.
19:e18003112019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen L, Ning J, Linghu L, Tang J, Liu N,
Long Y, Sun J, Lv C, Shi Y, Tao T, et al: USP13 facilitates a
ferroptosis-to-autophagy switch by activation of the
NFE2L2/NRF2-SQSTM1/p62-KEAP1 axis dependent on the KRAS signaling
pathway. Autophagy. 21:565–582. 2025. View Article : Google Scholar :
|
|
55
|
Zhu L, Zhu D, Ran J, Li M, Lai Z, Zhou Y,
Luo L, Liu X, Mao K and Tian K: Autophagy aggravates multi-walled
carbon nanotube-induced ferroptosis by suppressing PGC-1
dependent-mitochondrial biogenesis in lung epithelial cells. Chem
Biol Interact. 400:1111582024. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Cao Z, Tian K, Ran Y, Zhou H, Zhou L, Ding
Y and Tang X: Beclin-1: A therapeutic target at the intersection of
autophagy, immunotherapy, and cancer treatment. Front Immunol.
15:15064262024. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Feng Y, Xu J, Shi M, Liu R, Zhao L, Chen
X, Li M, Zhao Y, Chen J, Du W and Liu P: COX7A1 enhances the
sensitivity of human NSCLC cells to cystine deprivation-induced
ferroptosis via regulating mitochondrial metabolism. Cell Death
Dis. 13:9882022. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hill SM, Wrobel L and Rubinsztein DC:
Post-translational modifications of Beclin 1 provide multiple
strategies for autophagy regulation. Cell Death Differ. 26:617–629.
2019. View Article : Google Scholar
|
|
59
|
Fujiwara N, Shibutani S, Ohama T and Sato
K: Protein phosphatase 6 dissociates the Beclin 1/Vps34 complex and
inhibits autophagy. Biochem Biophys Res Commun. 552:191–195. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhu L, He S, Huang L, Ren D, Nie T, Tao K,
Xia L, Lu F, Mao Z and Yang Q: Chaperone-mediated autophagy
degrades Keap1 and promotes Nrf2-mediated antioxidative response.
Aging Cell. 21:e136162022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Yang Y, Willis TL, Button RW, Strang CJ,
Fu Y, Wen X, Grayson PRC, Evans T, Sipthorpe RJ, Roberts SL, et al:
Cytoplasmic DAXX drives SQSTM1/p62 phase condensation to activate
Nrf2-mediated stress response. Nat Commun. 10:37592019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhou Y, Shen Y, Chen C, Sui X, Yang J,
Wang L and Zhou J: The crosstalk between autophagy and ferroptosis:
What can we learn to target drug resistance in cancer? Cancer Biol
Med. 16:630–646. 2019. View Article : Google Scholar
|
|
63
|
Ikeda F: Ubiquitin conjugating enzymes in
the regulation of the autophagy-dependent degradation pathway.
Matrix Biol. 100-101:23–29. 2021. View Article : Google Scholar
|
|
64
|
Kuang E, Qi J and Ronai Z: Emerging roles
of E3 ubiquitin ligases in autophagy. Trends Biochem Sci.
38:453–460. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Cajee UF, Hull R and Ntwasa M:
Modification by ubiquitin-like proteins: Significance in apoptosis
and autophagy pathways. Int J Mol Sci. 13:11804–11831. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Liu L, Chen X, Wu L, Huang K, Wang Z,
Zheng Y, Zheng C, Zhang Z, Chen J, Wei J, et al: Ubiquitin ligase
subunit FBXO9 inhibits V-ATPase assembly and impedes lung cancer
metastasis. Exp Hematol Oncol. 13:322024. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Park E and Chung SW: ROS-mediated
autophagy increases intracellular iron levels and ferroptosis by
ferritin and transferrin receptor regulation. Cell Death Dis.
10:8222019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wu SY, Chen JW, Liu HY, Wang YC, Chu YS,
Huang CY, Lan KY, Liu HS and Lan SH: Secretory autophagy promotes
Rab37-mediated exocytosis of tissue inhibitor of metalloproteinase
1. J Biomed Sci. 29:1032022. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Koundouros N and Poulogiannis G:
Reprogramming of fatty acid metabolism in cancer. Br J Cancer.
122:4–22. 2020. View Article : Google Scholar :
|
|
70
|
Guo JY, Karsli-Uzunbas G, Mathew R, Aisner
SC, Kamphorst JJ, Strohecker AM, Chen G, Price S, Lu W, Teng X, et
al: Autophagy suppresses progression of K-ras-induced lung tumors
to oncocytomas and maintains lipid homeostasis. Genes Dev.
27:1447–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhang Z, Sun J, Jin C, Zhang L, Wu L and
Tian G: Identification and validation of a fatty acid metabolism
gene signature for the promotion of metastasis in liver cancer.
Oncol Lett. 26:4572023. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Wang K, Wang S, Zhang Y, Xie L and Song X
and Song X: SNORD88C guided 2'-O-methylation of 28S rRNA regulates
SCD1 translation to inhibit autophagy and promote growth and
metastasis in non-small cell lung cancer. Cell Death Differ.
30:341–355. 2023. View Article : Google Scholar
|
|
73
|
Khilwani R and Singh S: Traversing through
the mechanistic event analysis in IL-6 and IL-17 signaling for a
new therapeutic paradigm in NSCLC. Int J Mol Sci. 25:12162024.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Xanthopoulou E, Lamprou I, Mitrakas AG,
Michos GD, Zois CE, Giatromanolaki A, Harris AL and Koukourakis MI:
Autophagy blockage up-regulates HLA-class-I molecule expression in
lung cancer and enhances anti-PD-L1 immunotherapy efficacy. Cancers
(Basel). 16:32722024. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Tang X, Ding H, Liang M, Chen X, Yan Y,
Wan N, Chen Q, Zhang J and Cao J: Curcumin induces ferroptosis in
non-small-cell lung cancer via activating autophagy. Thorac Cancer.
12:1219–1230. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Jo A, Bae JH, Yoon YJ, Chung TH, Lee EW,
Kim YH, Joh HM and Chung JW: Plasma-activated medium induces
ferroptosis by depleting FSP1 in human lung cancer cells. Cell
Death Dis. 13:2122022. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wang L, Li Q, Liu H and Li L: HPCAL1 is a
novel driver of autophagy-dependent ferroptosis. J Zhejiang Univ
Sci B. 24:1053–1056. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Debnath J, Gammoh N and Ryan KM: Autophagy
and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol.
24:560–575. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Niu X, You Q, Hou K, Tian Y, Wei P, Zhu Y,
Gao B, Ashrafizadeh M, Aref AR, Kalbasi A, et al: Autophagy in
cancer development, immune evasion, and drug resistance. Drug
Resist Updat. 78:1011702025. View Article : Google Scholar
|
|
80
|
Guo D, Cai S, Deng L, Xu W, Fu S, Lin Y,
Jiang T, Li Q, Shen Z, Zhang J, et al: Ferroptosis in pulmonary
disease and lung cancer: Molecular mechanisms, crosstalk
regulation, and therapeutic strategies. MedComm (2020).
6:e701162025. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Li Y, Hahn T, Garrison K, Cui ZH, Thorburn
A, Thorburn J, Hu HM and Akporiaye ET: The vitamin E analogue α-TEA
stimulates tumor autophagy and enhances antigen cross-presentation.
Cancer Res. 72:3535–3545. 2012.PubMed/NCBI
|
|
82
|
Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr
M, Hijlkema KJ, Coppes RP, Engedal N, Mari M and Reggiori F:
Chloroquine inhibits autophagic flux by decreasing
autophagosome-lysosome fusion. Autophagy. 14:1435–1455. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Li Y, Cao F, Li M, Li P, Yu Y, Xiang L, Xu
T, Lei J, Tai YY, Zhu J, et al: Hydroxychloroquine induced lung
cancer suppression by enhancing chemo-sensitization and promoting
the transition of M2-TAMs to M1-like macrophages. J Exp Clin Cancer
Res. 37:2592018. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Lee SM, Hewish M, Ahmed S,
Papadatos-Pastos D, Karapanagiotou E, Blackhall F, Ford A, Young R,
Garcia A, Arora A, et al: Hydroxychloroquine in combination with
platinum doublet chemotherapy as first-line treatment for
extensive-stage small cell lung cancer (study 15): A randomised
phase II multi-centre trial. Eur J Cancer. 215:1151622025.
View Article : Google Scholar
|
|
85
|
Fang X, Zeng J, Li Y, Yu H, Wu Z and Qi X:
Hydroxychloroquine loaded hollow apoferritin nanocages for cancer
drug repurposing and autophagy inhibition. Eur J Pharm Biopharm.
203:1144732024. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Bhatt V, Lan T, Wang W, Kong J, Lopes EC,
Wang J, Khayati K, Raju A, Rangel M, Lopez E, et al: Inhibition of
autophagy and MEK promotes ferroptosis in Lkb1-deficient
Kras-driven lung tumors. Cell Death Dis. 14:612023. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Pan X, Lin Z, Jiang D, Yu Y, Yang D, Zhou
H, Zhan D, Liu S, Peng G, Chen Z and Yu Z: Erastin decreases
radioresistance of NSCLC cells partially by inducing GPX4-mediated
ferroptosis. Oncol Lett. 17:3001–3008. 2019.PubMed/NCBI
|
|
88
|
Xiong C, Ling H, Huang YD, Dong H, Xie B,
Hao Q and Zhou X: AZD1775 synergizes with SLC7A11 inhibition to
promote ferroptosis. Sci China Life Sci. 68:204–218. 2025.
View Article : Google Scholar
|
|
89
|
Bow YD, Ko CC, Chang WT, Chou SY, Hung CT,
Huang JL, Tseng CH, Chen YL, Li RN and Chiu CC: A novel quinoline
derivative, DFIQ, sensitizes NSCLC cells to ferroptosis by
promoting oxidative stress accompanied by autophagic dysfunction
and mitochondrial damage. Cancer Cell Int. 23:1712023. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Liu C, Sun RL, Wang HM, Xia YH and Wang
YJ: Rabeprazole inhibits lung cancer progression by triggering
NLRP3/CASP-1/caspase-dependent pyroptosis. Int Immunopharmacol.
146:1138062025. View Article : Google Scholar
|
|
91
|
Cao W, Sun MY, Yu KN, Zhao L, Feng Y, Tan
C, Yang M, Wang Y, Zhu F, Chen L, et al: Exogenous carbon monoxide
promotes GPX4-dependent ferroptosis through ROS/GSK3β axis in
non-small cell lung cancer. Cell Death Discov. 10:422024.
View Article : Google Scholar
|
|
92
|
Xia H, Tai XJ, Cheng W, Wu Y, He D, Wang
LF, Liu H, Zhang SY, Sun YT, Liu HZ, et al: Metformin inhibits the
growth of SCLC cells by inducing autophagy and apoptosis via the
suppression of EGFR and AKT signalling. Sci Rep. 15:60812025.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Liu X and Sun Y, Lv X, Song M, Sun J and
Sun Y: Targeting lipid peroxidation-associated ferroptosis
suppresses lung carcinoma progression by regulating cell cycle
arrest. Int Immunopharmacol. 138:1125182024. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Zheng H, Chen H, Cai Y, Shen M, Li X, Han
Y, Deng X, Cao H, Liu J, Li H, et al: Hydrogen sulfide-mediated
persulfidation regulates homocysteine metabolism and enhances
ferroptosis in non-small cell lung cancer. Mol Cell.
84:4016–4030.e6. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Luo D, He F, Liu J, Dong X, Fang M, Liang
Y, Chen M, Gui X, Wang W, Zeng L, et al: Pseudolaric acid B
suppresses NSCLC progression through the ROS/AMPK/mTOR/autophagy
signalling pathway. Biomed Pharmacother. 175:1166142024. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Liu MH, Liu ZK and Liu F: An anti-tumor
protein PFAP specifically interacts with cholesterol-enriched
membrane domains of A549 cells and induces paraptosis and
endoplasmic reticulum stress. Int J Biol Macromol. 264:1306902024.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
O'Neill EJ, Sze NSK, Macpherson REK and
Tsiani E: Carnosic acid against lung cancer: Induction of autophagy
and activation of sestrin-2/LKB1/AMPK signalling. Int J Mol Sci.
25:19502024. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Hou G, Hu W, Sang Y, Gan X, Xu H, Hu Q and
Cao X: Corynoxine triggers cell death via activating PP2A and
regulating AKT-mTOR/GSK3β axes in NSCLC. Biochem Pharmacol.
222:1161102024. View Article : Google Scholar
|
|
99
|
Yin J, Ding L, Yao S, Huang J, Xiao Y,
Wang Y, Zhang B, Rehmutulla M, Gu L, Tong Q and Zhang Y: Y9, a
Gboxin analog, displays anti-tumor effect in non-small cell lung
cancer by inducing lysosomal dysfunction and apoptosis. Bioorg
Chem. 153:1078202024. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Song C, Wang Z, Cao J, Dong Y and Chen Y:
Hesperetin alleviates aflatoxin B1 induced liver toxicity in mice:
Modulating lipid peroxidation and ferritin autophagy. Ecotoxicol
Environ Saf. 284:1168542024. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Xu C, Chen Y, Zhou Z, Yan Y, Fu W, Zou P
and Ni D: ML385, an Nrf2 inhibitor, synergically enhanced celastrol
triggered endoplasmic reticulum stress in lung cancer cells. ACS
Omega. 9:43697–43705. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Liu J, Zhou S, Chen J, Lin H, Li Y, Zhang
X, Chen S, Lv X and Zhao H: Nrf2 inhibition and NCOA4-mediated
ferritinophagy activation synergistically exacerbated
S-3'-hydroxy-7', 2', 4'-trimethoxyisoxane induced ferroptosis in
lung cancer cells. Chem Biol Interact. 406:1113532025. View Article : Google Scholar
|
|
103
|
Fu R, You Y, Wang Y, Wang J, Lu Y, Gao R,
Pang M, Yang P and Wang H: Sanggenol L induces ferroptosis in
non-small cell lung cancer cells via regulating the
miR-26a-1-3p/MDM2/p53 signaling pathway. Biochem Pharmacol.
226:1163452024. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Lin JW, Zhou Y, Xiao HP, Wu LL, Li PC,
Huang MD, Xie D, Xu P, Li XX and Li ZX: Antitumor effects of a
Sb-rich polyoxometalate on non-small-cell lung cancer by inducing
ferroptosis and apoptosis. Chem Sci. 15:15367–15376. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Gai C, Liu C, Wu X, Yu M, Zheng J, Zhang
W, Lv S and Li W: MT1DP loaded by folate-modified liposomes
sensitizes erastin-induced ferroptosis via regulating
miR-365a-3p/NRF2 axis in non-small cell lung cancer cells. Cell
Death Dis. 11:7512020. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Zhang C, Liu H, Li X, Xiao N, Chen H, Feng
H, Li Y, Yang Y, Zhang R, Zhao X, et al: Cold atmospheric plasma
enhances SLC7A11-mediated ferroptosis in non-small cell lung cancer
by regulating PCAF mediated HOXB9 acetylation. Redox Biol.
75:1032992024. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Li D, Zhang W, Wang R, Xie S, Wang Y, Guo
W, Huang Z, Lu C, Shan L, Liu H, et al: ROR1 CAR-T cells and
ferroptosis inducers orchestrate tumor ferroptosis via PC-PUFA2.
Biomark Res. 13:172025. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Huang F, Pang J, Xu L, Niu W, Zhang Y, Li
S and Li X: Hedyotis diffusa injection induces ferroptosis via the
Bax/Bcl2/VDAC2/3 axis in lung adenocarcinoma. Phytomedicine.
104:1543192022. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Zhang F, Huang B, Xu Y, Cao G, Shen M, Liu
C and Luo J: MISP suppresses ferroptosis via MST1/2 kinases to
facilitate YAP activation in non-small cell lung cancer. Adv Sci
(Weinh). 12:e24158142025. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Sun S, Jing X, Tong G, Chen C, Xie S, Wang
C, Chen D, Zhao J, Qi Y, Zhang W, et al: Loss of DDX24 inhibits
lung cancer progression by stimulating IKBKG splicing-mediated
autophagy. Theranostics. 15:1879–1895. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Zhang L, Lou W and Wang J: Advances in
nucleic acid therapeutics: Structures, delivery systems, and future
perspectives in cancer treatment. Clin Exp Med. 24:2002024.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Li X, Zhang X, Song L, Li Y, Liu A, Li L,
Nešić MD, Li D, Peng L, Wang C and Lin Q: Nanozyme as tumor energy
homeostasis disruptor to augment cascade catalytic therapy. ACS
Nano. 18:34656–34670. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Tsai T, Wu S, Lai Y, Wang H, Hou P, Huang
Y, Chen HH and Su W: CD44-hyaluronan mediating endocytosis of
iron-platinum alloy nanoparticles induces ferroptotic cell death in
mesenchymal-state lung cancer cells with tyrosine kinase inhibitor
resistance. Acta Biomater. 186:396–410. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Shu L, Luo P, Chen Q, Liu J, Huang Y, Wu
C, Pan X and Huang Z: Fibroin nanodisruptor with
ferroptosis-autophagy synergism is potent for lung cancer
treatment. Int J Pharm. 664:1245822024. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Nie Q, Chen W, Zhang T, Ye S, Ren Z, Zhang
P and Wen J: Iron oxide nanoparticles induce ferroptosis via the
autophagic pathway by synergistic bundling with paclitaxel. Mol Med
Rep. 28:1982023. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Li S, Lv J, Li Z, Zhang Q, Lu J, Huo X,
Guo M, Liu X, Li C, Wang J, et al: Overcoming multi-drug resistance
in SCLC: A synergistic approach with venetoclax and
hydroxychloroquine targeting the lncRNA LYPLAL1-DT/BCL2/BECN1
pathway. Mol Cancer. 23:2432024. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Zhao Y, Dhani S, Gogvadze V and
Zhivotovsky B: The crosstalk between SND1 and PDCD4 is associated
with chemoresistance of non-small cell lung carcinoma cells. Cell
Death Discov. 11:342025. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Rao S, Yang H, Penninger JM and Kroemer G:
Autophagy in non-small cell lung carcinogenesis: A positive
regulator of antitumor immunosurveillance. Autophagy. 10:529–531.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Deng J, Lin X, Qin J, Li Q, Zhang Y, Zhang
Q, Ji C, Shen S, Li Y, Zhang B and Lin N: SPTBN2 suppresses
ferroptosis in NSCLC cells by facilitating SLC7A11 membrane
trafficking and localization. Redox Biol. 70:1030392024. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Ma J, Zhang P, Wang Y, Lu M, Cao K, Wei S,
Qi C, Ling X and Zhu J: LncRNA HAR1A inhibits non-small cell lung
cancer growth by downregulating c-MYC transcripts and facilitating
its proteasomal degradation. Int Immunopharmacol. 142:1132642024.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Liu Z, Liu C, Fan C, Li R, Zhang S, Liu J,
Li B, Zhang S, Guo L, Wang X, et al: E3 ubiquitin ligase DTX2
fosters ferroptosis resistance via suppressing NCOA4-mediated
ferritinophagy in non-small cell lung cancer. Drug Resist Updat.
77:1011542024. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Zhang L, Xu Y, Cheng Z, Zhao J, Wang M,
Sun Y, Mi Z, Yuan Z and Wu Z: The EGR1/miR-139/NRF2 axis
orchestrates radiosensitivity of non-small-cell lung cancer via
ferroptosis. Cancer Lett. 595:2170002024. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Han F, Chen S, Zhang K, Zhang K, Wang M
and Wang P: Targeting Nrf2/PHKG2 axis to enhance radiosensitivity
in NSCLC. NPJ Precis Oncol. 8:1832024. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Liang J, Bi G, Huang Y, Zhao G, Sui Q,
Zhang H, Bian Y, Yin J, Wang Q, Chen Z and Zhan C: MAFF confers
vulnerability to cisplatin-based and ionizing radiation treatments
by modulating ferroptosis and cell cycle progression in lung
adenocarcinoma. Drug Resist Updat. 73:1010572024. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Ding W, Bao S, Zhao Q, Hao W, Fang K, Xiao
Y, Lin X, Zhao Z, Xu X, Cui X, et al: Blocking ACSL6 compromises
autophagy via FLI1-mediated downregulation of COLs to
radiosensitize lung cancer. Adv Sci (Weinh). 11:e24032022024.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Wen J, Zheng W, Zeng L, Wang B, Chen D,
Chen Y, Lu X, Shao C, Chen J and Fan M: LTF induces radioresistance
by promoting autophagy and forms an AMPK/SP2/NEAT1/miR-214-5p
feedback loop in lung squamous cell carcinoma. Int J Biol Sci.
19:1509–1527. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Lv S, Pan Q, Lu W, Zhang W, Wang N, Huang
L, Li L, Liu J, Ma J, Li Z, et al: Tenovin 3 induces apoptosis and
ferroptosis in EGFR 19del non small cell lung cancer cells. Sci
Rep. 14:76542024. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Lee WC, Moi SH, Yang SF, Tseng HH and Liu
YP: Downregulation of AATK enhances susceptibility to ferroptosis
by promoting endosome recycling in gefitinib-resistant lung cancer
cells. J Pathol. 265:422–436. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Jiang Z, Sun X, Li Y, Wang J, Wang C, Pan
Z and Yang Y: Anlotinib induced ferroptosis through the
p53/xCT/GPX4 pathway in non-small cell lung cancer. Transl Oncol.
53:1022892025. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Huang CY, Chen LJ, Chen CS, Wang CY and
Hong SY: MCL1 inhibition: A promising approach to augment the
efficacy of sorafenib in NSCLC through ferroptosis induction. Cell
Death Discov. 10:1372024. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zhao L, Deng H, Zhang J, Zamboni N, Yang
H, Gao Y, Yang Z, Xu D, Zhong H, van Geest G, et al: Lactate
dehydrogenase B noncanonically promotes ferroptosis defense in
KRAS-driven lung cancer. Cell Death Differ. 32:632–645. 2025.
View Article : Google Scholar :
|
|
132
|
Li N, Zuo R, He Y, Gong W, Wang Y, Chen L,
Luo Y, Zhang C, Liu Z, Chen P and Guo H: PD-L1 induces autophagy
and primary resistance to EGFR-TKIs in EGFR-mutant lung
adenocarcinoma via the MAPK signaling pathway. Cell Death Dis.
15:5552024. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Lyu X, Zeng L, Shi J, Ming Z, Li W, Liu B,
Chen Y, Yuan B, Sun R, Yuan J, et al: Essential role for
STAT3/FOXM1/ATG7 signaling-dependent autophagy in resistance to
icotinib. J Exp Clin Cancer Res. 41:2002022. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Ma C, Zhang X, Mo X, Yu Y, Xiao Z, Wu J,
Ding L, Lei C, Zhu Y and Zhang H: Xie-Bai-San increases NSCLC cells
sensitivity to gefitinib by inhibiting beclin-1 mediated
autophagosome formation. Phytomedicine. 125:1553512024. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Liu Q, Hu J, Li X, Gao H, Kong D and Jin
M: Glutamine transporter inhibitor enhances the sensitivity of
NSCLC to trametinib through GSDME-dependent pyroptosis. Biochem
Pharmacol. 233:1167962025. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Schläfli AM, Tokarchuk I, Parejo S, Jutzi
S, Berezowska S, Engedal N and Tschan MP: ALK inhibition activates
LC3B-independent, protective autophagy in EML4-ALK positive lung
cancer cells. Sci Rep. 11:90112021. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Yang Q, Sun K, Gao T, Gao Y, Yang Y, Li Z
and Zuo D: SIRT1 silencing promotes EMT and Crizotinib resistance
by regulating autophagy through AMPK/mTOR/S6K signaling pathway in
EML4-ALK L1196M and EML4-ALK G1202R mutant non-small cell lung
cancer cells. Mol Carcinog. 63:2133–2144. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Wu L, Liu J, Wang S, Bai M, Wu M, Gao Z,
Li J, Yu J, Liu J and Meng X: Negative correlation between
18F-RGD uptake via PET and tumoral PD-L1 expression in
non-small cell lung cancer. Front Endocrinol (Lausanne).
13:9136312022. View Article : Google Scholar
|
|
139
|
Gou Q, Che S, Chen M, Chen H, Shi J and
Hou Y: PPARγ inhibited tumor immune escape by inducing PD-L1
autophagic degradation. Cancer Sci. 114:2871–2881. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Young MJ, Wang SA, Chen YC, Liu CY, Hsu
KC, Tang SW, Tseng YL, Wang YC, Lin SM and Hung JJ: USP24-i-101
targeting of USP24 activates autophagy to inhibit drug resistance
acquired during cancer therapy. Cell Death Differ. 31:574–591.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Yuan Z, Yu T, Wang X, Meng K, Wang T, Wang
B, Xi Y, Wang C, Zeng C, Hu S, et al: Glutamine deprivation confers
immunotherapy resistance by inhibiting IFN-γ signaling in cancer
cells. Pharmacol Res. 213:1076432025. View Article : Google Scholar
|
|
142
|
Luo L and Xu G: Fascaplysin induces
apoptosis and ferroptosis, and enhances anti-PD-1 immunotherapy in
non-small cell lung cancer (NSCLC) by promoting PD-L1 expression.
Int J Mol Sci. 23:137742022. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Ke ZH, Chen Y, Yu T, Zhang Q, Xiang Y and
Lu KH: LRP1B suppresses immunotherapy efficacy in lung
adenocarcinoma by preventing ferroptosis. Cancer Med.
13:e704862024. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Diao JD, Jia YY, Dai EY, Liu J, Kang R,
Tang D, Han L, Zhong Y and Meng L: Ferroptotic therapy in cancer:
benefits, side effects, and risks. Mol Cancer. 23:892024.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Zhao X, Hu S, Zeng L, Liu X, Song Y, Zhang
Y, Chen Q, Bai Y, Zhang J, Zhang H, et al: Irradiation combined
with PD-L1−/− and autophagy inhibition enhances the
antitumor effect of lung cancer via cGAS-STING-mediated T cell
activation. iScience. 25:1046902022. View Article : Google Scholar
|
|
146
|
Li C, Zhao W, Geng D, Jin Y and Guan W:
Targeting the interplay of cGAS-STING and ferroptosis by
nanomedicine in the treatment of cancer. J Exp Clin Cancer Res.
44:2492025. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Ma L, Chen C, Zhao C, Li T, Ma L, Jiang J,
Duan Z, Si Q, Chuang TH, Xiang R and Luo Y: Targeting carnitine
palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes
with immunotherapy in lung cancer. Signal Transduct Target Ther.
9:642024. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Wang J, Liu Z, Hu T, Han L, Yu S, Yao Y,
Ruan Z, Tian T, Huang T, Wang M, et al: Nrf2 promotes progression
of non-small cell lung cancer through activating autophagy. Cell
Cycle. 16:1053–1062. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Gardner EE, Earlie EM, Li K, Thomas J,
Hubisz MJ, Stein BD, Zhang C, Cantley LC, Laughney AM and Varmus H:
Lineage-specific intolerance to oncogenic drivers restricts
histological transformation. Science. 383:eadj14152024. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Liu D, Wu L, Xu X, Yang S, Liu M, Hu M,
Ren S and Xu Y: Regimens combining radiation and immunotherapy for
cancer: Latest updates from 2024 ASCO annual meeting. J Hematol
Oncol. 17:842024. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Cheng Y, Bai L and Cui J: Harnessing
multi-omics approaches to decipher tumor evolution and improve
diagnosis and therapy in lung cancer. Biomark Res. 13:1402025.
View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Hsu CY, Askar S, Alshkarchy SS, Nayak PP,
Attabi KAL, Khan MA, Mayan JA, Sharma MK, Islomov S and Soleimani
Samarkhazan H: AI-driven multi-omics integration in precision
oncology: Bridging the data deluge to clinical decisions. Clin Exp
Med. 26:292025. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Li X, Yin D, Geng J, Xu Y, Xu Z, Yang X,
Li Q, Shang Z, Yang Z, Xu Z, et al: Machine learning-driven
multi-omics analysis identifies a prognostic gene signature
associated with programmed cell death and metabolism in
hepatocellular carcinoma. Biol Proced Online. 27:292025. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Kale M, Wankhede N, Pawar R, Ballal S,
Kumawat R, Goswami M, Khalid M, Taksande B, Upaganlawar A, Umekar
M, et al: AI-driven innovations in Alzheimer's disease: Integrating
early diagnosis, personalized treatment, and prognostic modelling.
Ageing Res Rev. 101:1024972024. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Yu G and Gong J: Targeting CSC-immune cell
crosstalk to overcome chemoresistance and enhance immunotherapy
efficacy. Front Immunol. 16:16208072025. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Fang C, Zhou P, Zhang X, He Y and Yang Q:
Artificial intelligence in oncology drug development and
management: A precision medicine perspective. Front Oncol.
15:16098272025. View Article : Google Scholar : PubMed/NCBI
|
